GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Gross Profit

Societal CDMO (FRA:RAH) Gross Profit : €16.77 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Gross Profit?

Societal CDMO's gross profit for the three months ended in Dec. 2023 was €7.06 Mil. Societal CDMO's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was €16.77 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Societal CDMO's gross profit for the three months ended in Dec. 2023 was €7.06 Mil. Societal CDMO's Revenue for the three months ended in Dec. 2023 was €25.42 Mil. Therefore, Societal CDMO's Gross Margin % for the quarter that ended in Dec. 2023 was 27.77%.

Societal CDMO had a gross margin of 27.77% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Societal CDMO was 48.62%. The lowest was 18.59%. And the median was 44.20%.

Warning Sign:

Societal CDMO Inc gross margin has been in long-term decline. The average rate of decline per year is -15.2%.


Societal CDMO Gross Profit Historical Data

The historical data trend for Societal CDMO's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Gross Profit Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.41 10.16 17.54 21.84 16.63

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.46 2.10 4.13 3.49 7.06

Competitive Comparison of Societal CDMO's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Gross Profit distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Gross Profit falls into.



Societal CDMO Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Societal CDMO's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=86.78 - 70.147
=16.63

Societal CDMO's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=25.418 - 18.359
=7.06

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.77 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Societal CDMO's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=7.06 / 25.418
=27.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Societal CDMO  (FRA:RAH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Societal CDMO had a gross margin of 27.77% for the quarter that ended in Dec. 2023 => Competition eroding margins


Societal CDMO Gross Profit Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines